357 related articles for article (PubMed ID: 25799416)
21. Molecular Mechanism of Cancer Susceptibility Associated with Fok1 Single Nucleotide Polymorphism of VDR in Relation to Breast Cancer.
Raza S; Dhasmana A; Bhatt MLB; Lohani M; Arif JM
Asian Pac J Cancer Prev; 2019 Jan; 20(1):199-206. PubMed ID: 30678432
[TBL] [Abstract][Full Text] [Related]
22. Serum Vitamin D status and VDR (
Faiz M; Younus A; Yasmin A
J Cancer Res Ther; 2023 Apr; 19(Supplement):S87-S92. PubMed ID: 37147988
[TBL] [Abstract][Full Text] [Related]
23. The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine.
Yamamoto H; Miyamoto K; Li B; Taketani Y; Kitano M; Inoue Y; Morita K; Pike JW; Takeda E
J Bone Miner Res; 1999 Feb; 14(2):240-7. PubMed ID: 9933478
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D receptor gene polymorphism is associated with metastatic breast cancer.
Ruggiero M; Pacini S; Aterini S; Fallai C; Ruggiero C; Pacini P
Oncol Res; 1998; 10(1):43-6. PubMed ID: 9613456
[TBL] [Abstract][Full Text] [Related]
25. Association of vitamin D receptor gene polymorphisms with prostate cancer risk in the Pakistani population.
Yousaf N; Afzal S; Hayat T; Shah J; Ahmad N; Abbasi R; Ramzan K; Jan R; Khan I; Ahmed J; Siraj S
Asian Pac J Cancer Prev; 2014; 15(22):10009-13. PubMed ID: 25520061
[TBL] [Abstract][Full Text] [Related]
26. Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.
Wang K; Wu G; Li J; Song W
BMC Cancer; 2016 Aug; 16(1):674. PubMed ID: 27553621
[TBL] [Abstract][Full Text] [Related]
27. Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study.
Rashid MU; Muzaffar M; Khan FA; Kabisch M; Muhammad N; Faiz S; Loya A; Hamann U
PLoS One; 2015; 10(10):e0141562. PubMed ID: 26517870
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.
Abbas S; Nieters A; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Breast Cancer Res; 2008; 10(2):R31. PubMed ID: 18419802
[TBL] [Abstract][Full Text] [Related]
29. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.
Tworoger SS; Gates MA; Lee IM; Buring JE; Titus-Ernstoff L; Cramer D; Hankinson SE
Cancer Res; 2009 Mar; 69(5):1885-91. PubMed ID: 19223536
[TBL] [Abstract][Full Text] [Related]
31. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D receptor gene polymorphisms affecting changes in visceral fat, waist circumference and lipid profile in breast cancer survivors supplemented with vitamin D3.
Kazemian E; Amouzegar A; Akbari ME; Moradi N; Gharibzadeh S; Jamshidi-Naeini Y; Khademolmele M; As'habi A; Davoodi SH
Lipids Health Dis; 2019 Aug; 18(1):161. PubMed ID: 31395070
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk.
Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
Pharmacogenetics; 2004 Apr; 14(4):239-45. PubMed ID: 15083068
[TBL] [Abstract][Full Text] [Related]
34. Genotyping of vitamin D receptor gene polymorphisms using mismatched amplification mutation assay in neonatal sepsis patients of Odisha, eastern India.
Das B; Patra S; Behera C; Suar M
Infect Genet Evol; 2016 Nov; 45():40-47. PubMed ID: 27535015
[TBL] [Abstract][Full Text] [Related]
35. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D receptor Cdx-2-dependent response of central obesity to vitamin D intake in the subjects with type 2 diabetes: a randomised clinical trial.
Shab-Bidar S; Neyestani TR; Djazayery A
Br J Nutr; 2015 Nov; 114(9):1375-84. PubMed ID: 26346470
[TBL] [Abstract][Full Text] [Related]
37. Association of vitamin D receptor gene variants, adiposity and colon cancer.
Ochs-Balcom HM; Cicek MS; Thompson CL; Tucker TC; Elston RC; J Plummer S; Casey G; Li L
Carcinogenesis; 2008 Sep; 29(9):1788-93. PubMed ID: 18628249
[TBL] [Abstract][Full Text] [Related]
38. Effects of the Cdx-2 polymorphism of the vitamin D receptor gene and lifestyle factors on bone mineral density in a representative sample of Japanese women: the Japanese Population-based Osteoporosis (JPOS) Study.
Morita A; Iki M; Dohi Y; Ikeda Y; Kagamimori S; Kagawa Y; Yoneshima H
Calcif Tissue Int; 2005 Dec; 77(6):339-47. PubMed ID: 16362455
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D receptor gene polymorphisms in breast cancer.
Buyru N; Tezol A; Yosunkaya-Fenerci E; Dalay N
Exp Mol Med; 2003 Dec; 35(6):550-5. PubMed ID: 14749534
[TBL] [Abstract][Full Text] [Related]
40. Cdx-2 polymorphism in the vitamin D receptor gene (VDR) marks VDR expression in monocyte/macrophages through VDR promoter methylation.
Meyer V; Bornman L
Immunogenetics; 2018 Aug; 70(8):523-532. PubMed ID: 29808256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
